Sign in

GILEAD SCIENCES, INC.

GILD

Share price not shown yet: live market data is not connected. Everything below comes from GILD’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
48%
rev growth + FCF margin
Revenue growth
+5.5%
TTM vs prior TTM
FCF margin
42.5%
ROE (TTM)
-20.6%
TTM NI ÷ avg equity
Net debt
$23.1B
total debt − cash & ST inv.
Dilution (YoY)
-0.1%
negative = buybacks
SBC / revenue
3.0%
TTM revenue
$30.5B

Revenue

$0B$2B$4B$6B$8BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$8B

EPS (diluted)

$-8.00$-6.00$-4.00$-2.00$0.00$2.00Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$-8.45

Operating

-100%-50%0%50%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26-133%

Net income

-$10B-$5B$0BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26-$10B

Net margin

-100%-50%0%50%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26-135%

Free cash flow vs. stock-based comp

FCFSBC
$0B$1B$2B$3B$4BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$3B

Operating cash flow vs. capex

OCFCapex
$0B$1B$2B$3B$4BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$4B

R&D vs. SG&A

R&DSG&A
$0.0B$0.5B$1.0B$1.5B$2.0BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$1.8B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…